发明名称 |
Modified BCG strains with reduced or eliminated activity of LSR2 and pharmaceutical composition comprising same |
摘要 |
<p>The invention discloses a live modified Mycobacterium bovis�BCG strain in which the lsr2 gene is inactivated or its expression is reduced and a pharmaceutical composition comprising the same for the treatment or prophylaxis of a mammal against challenge by mycobacteria or against cancer. The invention further discloses a method for the treatment or prophylaxis of a mammal against challenge by Mycobacterium tuberculosis or Mycobacterium bovis or against cancer by administering to the mammal the live modified Mycobacterium bovis�BCG strain or the pharmaceutical composition of the present invention.</p> |
申请公布号 |
GB2521573(A) |
申请公布日期 |
2015.06.24 |
申请号 |
GB20150007037 |
申请日期 |
2012.09.27 |
申请人 |
CHENGDU YONGAN PHARMACEUTICAL CO, LTD |
发明人 |
JUN LIU |
分类号 |
C12N1/21;A61K39/04;C12N1/36;C12N15/74 |
主分类号 |
C12N1/21 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|